Keros Therapeutics (KROS) Amortizatization of Intangibles (2019 - 2025)

Keros Therapeutics has reported Amortizatization of Intangibles for 7 years, with the latest figure at $622000.0 in Q4 2025.

• For the quarter ending Q4 2025, Amortizatization of Intangibles rose 8.74% year-over-year to $622000.0; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (up 32.42% YoY), and the FY2025 full-year result was $2.4 million, up 32.42% from the prior year.
• Amortizatization of Intangibles for Q4 2025 stood at $622000.0, up from $609000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $622000.0 in Q4 2025, with the low at $99000.0 in Q1 2021.
• Historically, Amortizatization of Intangibles has averaged $362150.0 across 5 years, with a median of $340000.0 in 2023.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles surged 157.14% — and 2024, when it plunged 35.06%.
• Keros Therapeutics' Amortizatization of Intangibles stood at $198000.0 in 2021, then surged by 62.12% to $321000.0 in 2022, then climbed by 4.36% to $335000.0 in 2023, then soared by 70.75% to $572000.0 in 2024, then grew by 8.74% to $622000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at $622000.0 (Q4 2025), $609000.0 (Q3 2025), and $595000.0 (Q2 2025), per Business Quant data.